Assessment of very early response evaluation with (18)F-FDG-PET/CT predicts survival in erlotinib treated NSCLC patients-A comparison of methods

We evaluated whether changes in (18)F-Fluoro-D-Glucose ((18)F-FDG)-uptake evaluated early during erlotinib treatment predict survival in non-small cell lung cancer (NSCLC) patients. Positron emission tomography (PET)/CT scans from 56 NSCLC patients before and after 7-10 days of erlotinib treatment w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Nucl Med Mol Imaging
Asıl Yazarlar: Fledelius, Joan, Winther-Larsen, Anne, Khalil, Azza A, Hjorthaug, Karin, Frøkiær, Jørgen, Meldgaard, Peter
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5840323/
https://ncbi.nlm.nih.gov/pubmed/29531861
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller